Werewolf Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/1/2026

1. AMZN
2. RBLX
3. AAPL
4. RDDT
5. COIN
6. NBIX
7. DXCM
8. FND
9. GH
10. GDDY

Go back to Werewolf Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Werewolf Therapeutics, Inc. (HOWL) Tops Q4 EPS by 16c

March 23, 2023 7:35 AM EDT

Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q4 EPS of ($0.39), $0.16 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $2.07 million.

For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.

... More